Barb Senters

Chief Compliance & Ethics Officer, Sonic Healthcare USA

Barb Senters is the Chief Compliance & Ethics Officer for Sonic Healthcare USA, a top three full service clinical lab. Her expertise lies in developing effective, risk based compliance strategies and maintaining an ethical culture with a focus on transparency. She has an extensive background in establishing and strengthening compliance programs at major health care companies. As an example, she successfully resolved the Ameritox Corporate Integrity Agreement, working closely with the Office of the Inspector General, Independent Monitor and senior leaders. Prior to joining Sonic, Ms. Senters was the Compliance Officer for Ameritox, a toxicology lab and previously owned a consulting business called Regulatory Solutions in which she provided compliance and human resources support to colleagues in various aspects of health care. She was the Chief Compliance Officer for Solstas Lab Partners with a focus on compliance due diligence for acquisitions. She also held a Senior Compliance role at Quest Diagnostics. She was a professional participant in developing the Office of Inspector General’s publication : “Resource Guide for Measuring Compliance Program Effectiveness”. Ms. Senters is a Certified Compliance & Ethics Professional (CCEP) and a certified Professional in Human Resources (PHR). She is also a certified Six-Sigma Greenbelt. She is an active member of the Health Care Compliance Association (HCCA) and was appointed as a “Lifetime Fellow” of the Health Ethics Trust.

Barb is speaking at

October 24, 2018
8:00 am - 3:30 pm
Columbia B


  • Beth Bailey (Speaker) Director, Strategic Development, TriCore Reference Laboratories
  • Lisa Jean Clifford (Speaker) COO & Chief Strategy Officer, Gestalt Diagnostics
  • Linda Smith (Speaker) Vice President, Laboratory Services, SSM Health
  • Steve Stonecypher (Speaker) Partner, Shipwright Healthcare Group
  • Barb Senters (Speaker) Chief Compliance & Ethics Officer, Sonic Healthcare USA
  • James M Crawford, MD, PhD (Speaker) Chair, Department of Pathology and Laboratory Medicine / Senior Vice President Laboratory Services, Zucker School of Medicine, Hofstra/Northwell / Northwell Health System
  • Patricia Goede (Speaker) VP Clinical Informatics, XIFIN, Inc.
  • Julie Ramage (Speaker) National Account Director, Diagnostics, Pfizer Oncology
  • Shally Madan (Speaker) Co-founder & COO, LuminateHealth


What does FutureLab look like? What does your lab need to focus on to be ready to operate in a Clinical Lab 2.0 environment?

In this one-day interactive Summit, strategic planning experts and lab leaders will guide attendees step-by-step through the process of connecting trends to trajectories and developing a competitive roadmap for your diagnostic lab using Clinical Lab 2.0 ideology.

In the morning sessions, we’ll conduct an external scan and learn about the market opportunities and threats facing laboratories, such as new customers, alternative markets and revenue streams, the compliance/legal environment, and non-traditional competition. We’ll also explore emerging FutureLab technology and innovation, such as artificial intelligence and innovation in pathology.

In the afternoon, we’ll do an internal scan. Attendees will learn how to assess their own labs’ strengths and weaknesses to defend against the threats and to maximize the opportunities. And finally, we’ll connect the dots and target specific strategies you need to become a successful FutureLab. You’ll walk away with a practical Clinical Lab 2.0 toolbox to facilitate future planning.

Session Objectives:

  • Engage subject matter experts to explore external market opportunities and threats in order to paint a canvas of FutureLab;
  • Target your FutureLab opportunities based on your lab’s strengths; begin to understand your lab’s possible gaps in FutureLab; and
  • Determine action steps and target additional learning at Lab Institute 2018.

October 25, 2018
11:30 am - 12:15 pm
Regency B/C/D


  • Barb Senters (Speaker) Chief Compliance & Ethics Officer, Sonic Healthcare USA
  • Debra Maul (Speaker) Speaker
  • Andrea L. Treese Berlin (Speaker) Senior Counsel, US Dept of Health and Human Services, Office of the Inspector General, Office of Counsel to the Inspector General


In 2010 Ameritox settled a False Claims Act case for $16.3M and entered into a Corporate Integrity Agreement (CIA) with the Department of Health and Human Services Office of Inspector General (OIG). Andrea Treese Berlin was the attorney who handled that matter on behalf of the OIG. Barb Senters (now of Sonic Healthcare) was, thereafter, hired as the Chief Compliance Officer to administer and, ultimately, close out the CIA. One of her first steps was to invite the whistleblower, Debra Maul, to meet with company leaders to understand what led to her becoming a whistleblower. In this session, Ms. Maul, Ms. Senters, and Ms. Berlin will discuss the events leading up to the case and will outline how laboratories can strengthen the effectiveness of their compliance programs, create a culture of compliance to address whistleblowers’ concerns before they become qui tam relators, and use their compliance program to preemptively identify and address any issues as they arise. 

In this session, you will learn:

  • What factors within an organization might lead someone to become a whistleblower
  • How to strengthen your compliance program and create a corporate culture of compliance that addresses whistleblowers’ concerns before they become qui tam relators
  • How to use your compliance program to preemptively identify and address any issues as they arise


Add to my calendar

Add to Google Add to Outlook (.ics)

Create your personal schedule through the official app, Whova!

Get Started